Effects of hyaluronan and SPARC on fibroproliferative events assessed in an in vitro bladder acellular matrix model

Biomaterials

Volumn 27, Issue 20, 2006, Pages 3825-3835

  Brown, Allison L ^a   Ringuette, Murice J ^b   Prestwich, Glenn D ^c   Bagli, Darius J ^d   Woodhouse, Kimberly A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF UTAH   (United States)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Bladder tissue engineering; Co culture; Extracellular matrix; Hyaluronan hyaluronic acid; Matrix metalloproteinase; Smooth muscle cell

Indexed keywords

BLADDER TISSUE ENGINEERING; CO-CULTURE; EXTRACELLULAR MATRIX; HYALURONAN/HYALURONIC ACID;

BIOLOGICAL ORGANS; CELLS; MUSCLE; PROTEINS; SCAFFOLDS; TISSUE;

BIOMATERIALS;

BIOMATERIAL; GELATINASE; GLYCOPROTEIN; HYALURONIC ACID; OSTEONECTIN; SPARC PEPTIDE 4.2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLADDER; BLADDER ACELLULAR MATRIX; CELL FUNCTION; CELL PROLIFERATION; COCULTURE; COMPOSITE MATERIAL; CONTROLLED STUDY; CROSS LINKING; DISULFIDE BOND; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; MOUSE; MUSCLE FIBER CONTRACTION; NONHUMAN; PRIORITY JOURNAL; SCAFFOLD; SCAR FORMATION; SMOOTH MUSCLE FIBER; TISSUE ENGINEERING; TISSUE REPAIR; UROTHELIUM;

3T3 CELLS; ANIMALS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELLS, CULTURED; EXTRACELLULAR MATRIX; GELATINASES; HYALURONIC ACID; MICE; MYOCYTES, SMOOTH MUSCLE; OSTEONECTIN; PEPTIDES; REGENERATION; SWINE; TISSUE ENGINEERING; URINARY BLADDER;

ANIMALIA;

EID: 33646010629     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.02.040     Document Type: Article

References (39)

1. Brown A.L., Brook-Allred T.T., Waddell J.E., White J., Werkmeister J.A., Ramshaw J.A., et al. Bladder acellular matrix as a substrate for studying in vitro bladder smooth muscle-urothelial cell interactions. Biomaterials 26 5 (2005) 529-543
2. Brown A.L., Farhat W., Merguerian P.A., Wilson G.J., Khoury A.E., and Woodhouse K.A. 22 week assessment of bladder acellular matrix as a bladder augmentation material in a porcine model. Biomaterials 23 10 (2002) 2179-2190
3. Li H., Liu Y., Shu X.Z., Gray S.D., and Prestwich G.D. Synthesis and biological evaluation of cross-linked hyaluronan-mitomycin C hydrogel. Biomacromolecules 5 3 (2004) 895-902
4. Liu Y., Shu X.Z., and Prestwich G.D. Biocompatibility and stability of disulfide-crosslinked hyaluronan films. Biomaterials 26 23 (2005) 4737-4746
5. Liu Y., Shu X.Z., Gray S.D., and Prestwich G.D. Disulfide-crosslinked hyaluronan-gelatin hydrogel sponge: growth of fibrous tissue in vivo. J Biomed Mater Res 68A 1 (2004) 142-149
6. Peattie R.A., Nayate A.P., Firpo M.A., Shelby J., Fisher R.J., and Prestwich G.D. Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants. Biomaterials 25 14 (2004) 2789-2798
7. Shu X.Z., Liu Y., Palumbo F.S., Luo Y., and Prestwich G.D. In situ crosslinkable hyaluronan hydrogels for tissue engineering. Biomaterials 25 7-8 (2004) 1339-1348
8. Sage E.H., and Bornstein P. Minireview: extracellular proteins that modulate cell-matrix interactions: SPARC, tenascin, and thrombospondin. J Biol Chem 266 (1991) 14831-14834
9. ++-binding sites modulate cell shape. J Cell Biol 111 6 (1990) 3065-3076
10. Murphy-Ullrich J.E., Lane T.F., Pallero M.A., and Sage E.H. SPARC mediates focal adhesion disassembly in endothelial cells through a follistatin-like region and the calcium-binding-EF-hand. J Cell Biochem 57 (1995) 341-350
11. Abe K., Hibino T., Mishima H., and Shimomura Y. The cytokine regulation of SPARC production by rabbit corneal epithelial cells and fibroblasts in vitro. Cornea 23 2 (2004) 172-179
12. Francki A., McClure T.D., Brekken R.A., Motamed K., Murri C., Wang T., et al. SPARC regulates TGF-β1-dependent signaling in primary glomerular mesangial cells. J Cell Biochem 91 (2004) 915-925
13. Kupprion C., Motamed K., and Sage E.H. SPARC (BM-40, Osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J Biol Chem 273 (1998) 29635-29640
14. Raines E.W., Lane T.F., Iruela-Arispe M.L., Ross R., and Sage E.H. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci USA 89 4 (1992) 1281-1285
15. Lane T.F., Iruela-Arispe M.L., Johnson R.S., and Sage E.H. SPARC is a source of copper-binding peptides that stimulate angiogenesis. J Cell Biol 125 4 (1994) 929-943
16. Basu A., Kligman K.H., Samulewicz S.J., and Howe C.C. Impaired wound healing in mice deficient in a matricellular protein SPARC. BMC Cell Biol 2 (2001) 15-23
17. Bradshaw A.D., Puolakkainen P., Dasgupta J., Davidson J.M., Wight T.N., and Helene Sage E. SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength. J Invest Dermatol 120 6 (2003) 949-955
18. Bradshaw A.D., Reed M.J., and Sage E.H. SPARC-null mice exhibit accelerated cutaneous wound closure. J Histochem Cytochem 50 1 (2002) 1-10
19. Puolakkainen P., Bradshaw A.D., Kyriakides T.R., Reed M., Brekken R., Wight T., et al. Compromised production of extracellular matrix in mice lacking secreted protein, acidic and rich in cysteine (SPARC) leads to a reduced foreign body reaction to implanted biomaterials. Am J Pathol 162 2 (2003) 627-635
20. Sage E.H., Bassuk J.A., Yost J.C., Folkman M.J., and Lane T.F. Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca(2+)-binding EF-hand sequence. J Cell Biochem 57 1 (1995) 127-140
21. Tremble P.M., Lane T.F., Sage E.H., and Werb Z. SPARC a secreted protein associated with morphogenesis and tissue remodeling, induces expression of matrix metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway. J Cell Biol 121 6 (1993) 1144-1433
22. Shu X.Z., Liu Y., Luo Y., Roberts M.C., and Prestwich G.D. Disulfide cross-linked hyaluronan hydrogels. Biomacromolecules 3 (2002) 1304-1311
23. Mason I.J., Murphy D., Munke M., Francke U., Elliott R.W., and Hogan B.L. Developmental and transformation-sensitive expression of the SPARC gene on mouse chromosome 11. EMBO J 5 8 (1986) 1831-1837
24. Funk S.E., and Sage E.H. Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts. J Cell Physiol 154 (1993) 53-63
25. Stocum D.L. Vertebrate regeneration. Semin Cell Dev Biol 10 4 (1999) 433-440
26. Bullard K.M., Longaker M.T., and Lorenz H.P. Fetal wound healing: current biology. World J Surg 27 (2003) 54-61
27. Garg H.G., and Longaker M.T. Scarless wound healing (2000), Marcel Dekker, New York
28. Toole B.P. Hyaluronan in morphogenesis. Semin Cell Dev Biol 12 (2001) 79-87
29. Bradshaw A.D., and Sage E.H. SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107 9 (2001) 1049-1054
30. Huynh M.H., Hong H., Delovitch S., Desser S., and Ringuette M. Association of SPARC/osteonectin/BM-40 with extracellular and intracellular components of the ciliated surface ectoderm of Xenopus embryos. Cell Motil Cytoskel 47 (2000) 154-162
31. Martinek N., Zou R., Berg M., Sodek J., and Ringuette M. Evolutionary conservation and association of SPARC with the basal lamina in Drosophila. Dev Genes Evol 212 (2002) 124-133
32. Murphy-Ullrich J.E. The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state?. J Clin Invest 107 7 (2001) 785-790
33. Bradshaw A.D., Francki A., Motamed K., Howe C., and Sage E.H. Primary mesenchymal cells isolated from SPARC-null mice exhibit altered morphology and rates of proliferation. Mol Biol Cell 10 5 (1999) 1569-1579
34. Motamed K., Funk S.E., Koyama H., Ross R., Raines E.W., and Sage E.H. Inhibition of PDGF-stimulated and matrix-mediated proliferation of human vascular smooth muscle cells by SPARC is independent of changes in cell shape or cyclin-dependent kinase inhibitors. J Cell Biochem 84 (2002) 759-771
35. 2+-dependent binding to the extracellular matrix. J Cell Biol 109 1 (1989) 341-356
36. Shankavaram U.T., DeWitt D.L., Funk S.E., Sage E.H., and Wahl L.M. Regulation of human monocyte matrix metalloproteinases by SPARC. J Cell Physiol 173 3 (1997) 327-334
37. Kajita M., Itoh Y., Chiba T., Mori H., Okada A., Kinoh H., et al. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 153 5 (2001) 893-904
38. Mori H., Tomari T., Koshikawa N., Kajita M., Itoh Y., Sato H., et al. CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. EMBO J 21 15 (2002) 3949-3959
39. Gilles C., Bassuk J.A., Pulyaeva H., Sage E.H., Foidart J.M., and Thompson E.W. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. Cancer Res 58 23 (1998) 5529-5536